CMS is approving this time-limited state plan amendment (SPA) to respond to the COVID-19 national emergency. The purpose of this amendment is to cover and set reimbursement rates for the administration of EUA monoclonal antibody COVID-19 treatment by authorized EMS providers to state defined eligible beneficiaries.
State
Topics
Approval Date
Effective Date
File 3 - Attachment Media